BioMarin Pharmaceutical, Inc. (BMRN)
58.13
+0.98
(+1.71%)
USD |
NASDAQ |
Feb 06, 16:00
58.14
+0.01
(+0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical SG&A Expense (TTM) : 973.41M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| Merck & Co., Inc. | 10.73B |
| Gilead Sciences, Inc. | 5.886B |
| AbbVie, Inc. | 14.01B |
| Amgen, Inc. | 7.05B |